Literature DB >> 25729794

[Is the waiver of chemotherapy for small, node-negative breast cancer justified? ].

Marie-Luise Sautter-Bihl, Felix Sedlmayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25729794     DOI： 10.1007/s00066-014-0771-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery.

Authors:  W F Athas; M Adams-Cameron; W C Hunt; A Amir-Fazli; C R Key
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  How low should we go? The search for balance in management of small human epidermal growth factor receptor 2-positive breast cancers.

Authors:  Katherine E Reeder-Hayes; Lisa A Carey
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544

3.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

4.  Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial.

Authors:  M Untch; R D Gelber; C Jackisch; M Procter; J Baselga; R Bell; D Cameron; M Bari; I Smith; B Leyland-Jones; E de Azambuja; P Wermuth; R Khasanov; F Feng-Yi; C Constantin; J I Mayordomo; C-H Su; S-Y Yu; A Lluch; E Senkus-Konefka; C Price; F Haslbauer; T Suarez Sahui; V Srimuninnimit; M Colleoni; A S Coates; M J Piccart-Gebhart; A Goldhirsch
Journal:  Ann Oncol       Date:  2008-02-21       Impact factor: 32.976

5.  Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.

Authors:  David J Sher; Eve Wittenberg; W Warren Suh; Alphonse G Taghian; Rinaa S Punglia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-27       Impact factor: 7.038

6.  Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.

Authors:  Ines Vaz-Luis; Rebecca A Ottesen; Melissa E Hughes; Rizvan Mamet; Harold J Burstein; Stephen B Edge; Ana M Gonzalez-Angulo; Beverly Moy; Hope S Rugo; Richard L Theriault; Jane C Weeks; Eric P Winer; Nancy U Lin
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544

7.  Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system.

Authors:  Louis Fehrenbacher; Angela M Capra; Charles P Quesenberry; Regan Fulton; Parveen Shiraz; Laurel A Habel
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.